14 results
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... HumanPapillomavirus #IDSA ... #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus Infected Individuals
Induction therapy:
 • AmBd (0.7–1.0
IDSA Treatment Recommendations ... Itraconazole Consolidation ... Meningoencephalitis #IDSA ... #Treatment #management ... #cryptococcus #HIVAIDS
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
(IDSA 2021): ... 10 mg/kg IV x 1 ... /severe CDI IDSA ... #diagnosis #management ... #IDSA #gastroenterology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... 4–6 mL QID or 1– ... candida #mucosal #IDSA ... #management #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
IDSA Recommendations ... #Encephalitis #IDSA ... #Prevention #Treatment ... opportunistic #infections ... #HIVAIDS #management
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
IDSA Recommendations ... • Valacyclovir 1 ... HerpesSimplex #HSV #IDSA ... #management #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Cryptococcosis in HIV-AIDS
Treatment for cryptococcosis consists of 3 phases: induction,
IDSA Recommendations ... PO for at least 1 ... #Cryptococcus #IDSA ... #management #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
IDSA Recommendations ... ) for 1–4 doses ... Cytomegalovirus #CMV #IDSA ... #management #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... mg/kg on days 1– ... Leishmaniasis #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Varicella Zoster Virus (VZV) Infections in HIV-AIDS
Pre-Exposure Prevention of VZV
IDSA Recommendations ... health-care provider diagnosis ... • Valacyclovir 1 ... #Zoster #VZV #IDSA ... #infections #HIVAIDS